Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes

BACKGROUND: Basal continuous subcutaneous insulin infusion (CSII) therapy at a fixed rate may effectively improve glycemic control in patients with type 2 diabetes when oral antidiabetic treatment fails. Regimens of simple constant subcutaneous delivery of insulin may provide theoretical advantages...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Parkner, Tina, Laursen, Torben, Chen, Jian-Wen, Møller, Marianne K., Thomsen, Henrik F., Jørgensen, Christina, Smedegaard, Jørgen S., Lauritzen, Torsten, Christiansen, Jens S.
Formato: Artigo
Idioma:Inglês
Publicado: Diabetes Technology Society 2007
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2769649/
https://ncbi.nlm.nih.gov/pubmed/19885138
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares